COVID-19: Current understanding of its Pathophysiology, Clinical presentation and Treatment
A Parasher - Postgraduate medical journal, 2021 - academic.oup.com
Background The severe acute respiratory syndrome (SARS) coronavirus-2 is a novel
coronavirus belonging to the family Coronaviridae and is now known to be responsible for …
coronavirus belonging to the family Coronaviridae and is now known to be responsible for …
Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment
In the past two decades, the world has faced several infectious disease outbreaks. Ebola,
Influenza A (H1N1), SARS, MERS, and Zika virus have had a massive global impact in terms …
Influenza A (H1N1), SARS, MERS, and Zika virus have had a massive global impact in terms …
Retracted: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
P Gautret, JC Lagier, P Parola, L Meddeb, M Mailhe… - 2020 - Elsevier
French Confirmed COVID-19 patients were included in a single arm protocol from early 32
March to March 16th, to receive 600mg of hydroxychloroquine daily and their viral load in 33 …
March to March 16th, to receive 600mg of hydroxychloroquine daily and their viral load in 33 …
[HTML][HTML] Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards
B La Scola, M Le Bideau, J Andreani, VT Hoang… - European Journal of …, 2020 - Springer
In a preliminary clinical study, we observed that the combination of hydroxychloroquine and
azithromycin was effective against SARS-CoV-2 by shortening the duration of viral load in …
azithromycin was effective against SARS-CoV-2 by shortening the duration of viral load in …
An update on current therapeutic drugs treating COVID-19
The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has presented unprecedented …
respiratory syndrome coronavirus 2 (SARS-CoV-2) has presented unprecedented …
[HTML][HTML] Treatment options for COVID-19: The reality and challenges
SS Jean, PI Lee, PR Hsueh - Journal of microbiology, immunology and …, 2020 - Elsevier
An outbreak related to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
was first reported in Wuhan, China in December 2019. An extremely high potential for …
was first reported in Wuhan, China in December 2019. An extremely high potential for …
COVID-19: present and future challenges for dental practice
COVID-19 was declared a pandemic by the World Health Organization, with a high fatality
rate that may reach 8%. The disease is caused by SARS-CoV-2 which is one of the …
rate that may reach 8%. The disease is caused by SARS-CoV-2 which is one of the …
Mycoplasma pneumoniae from the respiratory tract and beyond
KB Waites, L **ao, Y Liu, MF Balish… - Clinical microbiology …, 2017 - Am Soc Microbiol
Mycoplasma pneumoniae is an important cause of respiratory tract infections in children as
well as adults that can range in severity from mild to life-threatening. Over the past several …
well as adults that can range in severity from mild to life-threatening. Over the past several …
Viral bronchiolitis
Viral bronchiolitis is a common clinical syndrome affecting infants and young children.
Concern about its associated morbidity and cost has led to a large body of research that has …
Concern about its associated morbidity and cost has led to a large body of research that has …
Role of viruses in asthma
Respiratory viral infections are the most important triggers of asthma exacerbations.
Rhinovirus (RV), the common cold virus, is clearly the most prevalent pathogen constantly …
Rhinovirus (RV), the common cold virus, is clearly the most prevalent pathogen constantly …